🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A New review explains how SARS-2 spike protein enables viral entry into host cells & how mutations affect its function. It explores how structural changes in spike contribute to immune escape & transmissibility of new variants w/ implications for vaccine & therapeutic design 1/

Our study on CoVFit, an AI that predicts the fitness of SARS-CoV-2 from spike protein sequences, is now out in Nat Commun! CoVFit helps uncover viral evolutionary mechanisms, detect emerging variants, and forecast viral evolution! nature.com/articles/s4146…

Published today📣 Our nasal booster in the "Prime & Spike" vaccine works without adjuvants (which are needed to induce adaptive immunity but also cause inflammation). Dong-il Kwon 🇰🇷 Tianyang Mao Benjamin Israelow et al. asked how this is possible. (1/) nature.com/articles/s4159…

Thrilled to share my first paper in Nature Immunology with Tianyang Mao and Benjamin Israelow in the Prof. Akiko Iwasaki lab! We uncover key mechanisms that can guide the design of safe and effective mucosal vaccines, critical tools for future pandemic preparedness! 👉🏻 nature.com/articles/s4159…

This newly published study was co-funded through our Johadamis Award, granted to Prof. Akiko Iwasaki Prof. Akiko Iwasaki and Amy Proal Amy Proal, PhD. 💙 You can read the full study here: academic.oup.com/jimmunol/advan…

Published today! Victoria Bastos, Kerrie Greene et al found two distinct immunotypes of ME/CFS based on the cerebrospinal fluid analysis. Great collaboration with Michael VanElzakker Amy Proal, PhD and the Bragée clinic in Sweden. (1/) academic.oup.com/jimmunol/artic…

It is such a joy to do science with such good friends! Thank you for being such amazing coworkers and friends, Victoria and Kerrie Greene 💜💚🩷

They got twins!!!

Our new study on ME/CFS is out in The Journal of Immunology !! Given the heterogeneity of #mecfs, it is so important we continue to dive deep into this disease to further differentiate pathophysiology. Truly enjoyed this work every step of the way. Check it out below!

FINGER OF GOD!!! #OKWX

this song really is perfect

Super excited to see this very cool work published in Nature Communications on SFTSV by Marine Petit from her time at .MRC-Uni of Glasgow Centre for Virus Research #tick #bunyavirus #lovevirology 🕷️ 🦠 🔗 nature.com/articles/s4146…

Excellent, epic review of HPAI H5N1! 👉nature.com/articles/s4157…

Think coronavirus spikes have run out of surprises? Think again. Our latest preprint dives into the highly unusual spikes of marine mammal coronaviruses. biorxiv.org/content/10.110… This #cryoEM study was led by Ruben Hulswit, with key contributions from an amazing team.

What we know about the safety, efficacy of mRNA vaccines amid recent scrutiny - my comments and interview with ⁦Mary Kekatos⁩ ⁦ABC News⁩ abcnews.go.com/Health/safety-…

Without its international students, Harvard is not Harvard. hrvd.me/IntStudents25t

For those of you who aren't aware, cancelling Harvard's F and J visas does not just affect students. It also affects many, many postdoctoral researchers. And critically, it affects OPT holders. These are graduates who stayed here to work in the US, they cannot "transfer"

25 years ago, I came to Stanford on a J1 visa and worked so hard to be worthy of that privilege. Today, I lead Immunology at Mount Sinai and I am the one who feel privileged when brilliant international students chose to join us.

🚨 Nipah virus poses a future #pandemic risk. New cases in Kerala, India further highlight the need for a One Health approach. Read more in our recent interdisciplinary and multi-institutional collaborative article published in Nature Microbiology #LZCI : nature.com/articles/s4156…

🚨 New paper out in Nature Communications! 🚨 Our study shows that multiple Omicron variants emerged independently across northeastern South Africa, with Gauteng as a key hub of early spread. 🔗 Read the open-access article: nature.com/articles/s4146… #SARSCoV2 #COVID19 #Omicron